Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain
暂无分享,去创建一个
Kjell Någren | Jussi Hirvonen | Jarmo Hietala | Antti Pertovaara | J. Hirvonen | K. Någren | J. Hietala | A. Pertovaara | J. Kajander | N. Hagelberg | I. Martikainen | H. Mansikka | Ilkka K. Martikainen | Nora Hagelberg | Jaana Kajander | Heikki Mansikka
[1] A. Ramage,et al. Influence of 5‐HT1A Receptor Agonists on Sympathetic and Parasympathetic Nerve Activity , 1990, Journal of cardiovascular pharmacology.
[2] Oberg Pa,et al. Laser-Doppler flowmetry. , 1990 .
[3] J. Micó,et al. The role of 5-HT1A receptors in research strategy for extensive pain treatment. , 2006, Current topics in medicinal chemistry.
[4] J. Hornung,et al. The human raphe nuclei and the serotonergic system , 2003, Journal of Chemical Neuroanatomy.
[5] B. Wallin,et al. Neural control of human skin blood flow. , 1990, Journal of the autonomic nervous system.
[6] M. Minchin,et al. Characterisation of the Binding of [3H]WAY‐100635, a Novel 5‐Hydroxytryptamine1A Receptor Antagonist, to Rat Brain , 1995, Journal of neurochemistry.
[7] B. Vogt. Pain and emotion interactions in subregions of the cingulate gyrus , 2005, Nature Reviews Neuroscience.
[8] N. El-Yassir,et al. A 5-HT1-type receptor mediates the antinociceptive effect of nucleus raphe magnus stimulation in the rat , 1990, Brain Research.
[9] Victoria Arango,et al. Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] M. Carli,et al. The 5-HT1A receptor agonist 8-OH-DPAT reduces rats’ accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT1A receptors , 2000, Psychopharmacology.
[11] A. Apkarian,et al. Representation of pain in the brain , 2006 .
[12] F. Colpaert. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief. , 2006, Current opinion in investigational drugs.
[13] Sean P David,et al. A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans , 2005, The Journal of Neuroscience.
[14] J. Tack,et al. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome , 2005, Gut.
[15] Tipu Z. Aziz,et al. Stimulating the human midbrain to reveal the link between pain and blood pressure , 2006, Pain.
[16] A. Pertovaara,et al. 5-HT(1A) receptors in endogenous regulation of neuropathic hypersensitivity in the rat. , 2006, European journal of pharmacology.
[17] Karl J. Friston,et al. Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems , 2005, The European journal of neuroscience.
[18] Ralph Myers,et al. Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.
[19] R. Malekzadeh,et al. The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study , 2005, Alimentary pharmacology & therapeutics.
[20] K. Någren,et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity , 2002, PAIN.
[21] J. Lance,et al. Plasma serotonin in patients with chronic tension headaches. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[22] M. Bushnell,et al. A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. , 1992, Somatosensory & motor research.
[23] A. Rissanen,et al. Brain serotonin 1A receptor binding in bulimia nervosa , 2004, Biological Psychiatry.
[24] I A Cliffe,et al. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.
[25] W. Riedel,et al. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls , 2004, Gut.
[26] P. U. Rani,et al. An Evaluation of Antidepressants in Rheumatic Pain Conditions , 1996, Anesthesia and analgesia.
[27] Q. Lin,et al. Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors. , 1996, The Journal of pharmacology and experimental therapeutics.
[28] M. Rowbotham,et al. Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial. , 2005, The journal of pain : official journal of the American Pain Society.
[29] S. McMahon,et al. Wall and Melzack's textbook of pain , 2006 .
[30] A. Eschalier,et al. Serotonin and Experimental Pain in Healthy Young Volunteers , 2003, The Clinical journal of pain.
[31] J. Kajander,et al. Brain Serotonin 1A Receptor Binding in Bulimia , 2004 .
[32] M Slifstein,et al. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. , 2001, Nuclear medicine and biology.
[33] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[34] Qing-ping Wang,et al. The dorsal raphe: An important nucleus in pain modulation , 1994, Brain Research Bulletin.
[35] E. Azmitia,et al. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.
[36] K. Brøsen,et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.
[37] D. Wright,et al. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain , 1995, The Journal of comparative neurology.
[38] A. Pizzimenti,et al. Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder , 2005, European journal of pain.
[39] J. Tack,et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double‐blind, placebo‐controlled study , 2006, Alimentary pharmacology & therapeutics.
[40] A. Pertovaara,et al. Spatial integration of cold pressor pain sensation in humans , 2004, Neuroscience Letters.
[41] Ramin V. Parsey,et al. Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.
[42] Victoria Arango,et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.
[43] N. Schneiderman,et al. Blood pressure reactivity and perception of pain during the forehead cold pressor test. , 1991, Psychophysiology.
[44] M Slifstein,et al. Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] F. Wolfe,et al. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. , 1997, The Journal of rheumatology.
[46] P. Keck,et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. , 2002, The American journal of medicine.
[47] Roger N. Gunn,et al. A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables , 2002, NeuroImage.
[48] A. Pertovaara,et al. Blood flow increase in the orofacial area of humans induced by painful stimulation , 1994, Brain Research Bulletin.
[49] J. Alger,et al. Brain responses associated with the Valsalva maneuver revealed by functional magnetic resonance imaging. , 2002, Journal of neurophysiology.
[50] Kjell Någren,et al. Measurement of Serotonin 5-HT1A Receptor Binding Using Positron Emission Tomography and [carbonyl-11C]WAY-100635—Considerations on the Validity of Cerebellum as a Reference Region , 2007 .
[51] M. Diksic,et al. Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[52] D. Zhuang,et al. Involvement of 5-hydroxytryptamine1A receptors in the descending anti-nociceptive pathway from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation , 2002, Neuroscience.
[53] Sati Mazumdar,et al. Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.
[54] E. Azmitia,et al. Cellular Localization of the 5-HT1A Receptor in Primate Brain Neurons and Glial Cells , 1996, Neuropsychopharmacology.
[55] F. Graeff,et al. Role of 5-HT in stress, anxiety, and depression , 1996, Pharmacology Biochemistry and Behavior.
[56] T. Shallice,et al. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. , 2003, Brain : a journal of neurology.
[57] C. Halldin,et al. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[58] S C Gandevia,et al. Neural sites involved in the sustained increase in muscle sympathetic nerve activity induced by inspiratory capacity apnea: a fMRI study. , 2006, Journal of applied physiology.
[59] F. Bloom,et al. The Biochemical Basis of Neuropharmacology , 1976 .
[60] C. Schmid,et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.
[61] P A Sargent,et al. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.